[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100432662":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":16,"locations":25,"responsibleParty":115,"collaborators":117,"id":124,"slug":125,"hasResults":126,"nctId":127,"briefTitle":128,"officialTitle":129,"acronym":7,"eligibilityCriteria":130,"healthyVolunteers":126,"sex":131,"minAge":132,"maxAge":133,"enrollmentInfo":134,"targetDuration":7,"studyType":137,"phases":7,"briefSummary":138,"conditions":139,"keywords":7,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":157},{"fullName":5,"class":6},"Haukeland University Hospital","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Biomarker analysis","Blood collection. Blood samples will be collected at diagnosis, during surveillance, during treatment and every 3-6 months",[13],{"name":14,"affiliation":5,"role":15},"Mette Pernille Myklebust, PhD","PRINCIPAL_INVESTIGATOR",[17,21],{"name":14,"role":18,"phone":19,"phoneExt":7,"email":20},"CONTACT","+47 41684492","mette.pernille.myklebust@helse-bergen.no",{"name":22,"role":18,"phone":23,"phoneExt":7,"email":24},"Olav Dahl, PhD","+47 55972081","olav.dahl@helse-bergen.no",[26,40,54,69,83,99],{"facility":5,"status":27,"city":28,"state":7,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Bergen","5021","Norway","NO",{"type":33,"coordinates":34},"Point",[35,36],5.32415,60.39299,{"lat":36,"lon":35},[39],{"name":14,"role":18,"phone":19,"phoneExt":7,"email":20},{"facility":41,"status":27,"city":42,"state":7,"zip":43,"country":30,"countryCode":31,"cosmosGeoPoint":44,"geoPoint":48,"contacts":49},"Haugesund Hospital","Haugesund","5528",{"type":33,"coordinates":45},[46,47],5.268,59.41378,{"lat":47,"lon":46},[50],{"name":51,"role":18,"phone":52,"phoneExt":7,"email":53},"Bogdan Stefan Bercea, MD","+47 52 73 20 00","bogdan.stefan.bercea@helse-fonna.no",{"facility":55,"status":56,"city":57,"state":7,"zip":58,"country":30,"countryCode":31,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Oslo University Hospital","NOT_YET_RECRUITING","Oslo","0379",{"type":33,"coordinates":60},[61,62],10.74609,59.91273,{"lat":62,"lon":61},[65],{"name":66,"role":18,"phone":67,"phoneExt":7,"email":68},"Helene Negaard, MD, PhD","+47 22 93 40 00","UXHEGA@ous-hf.no",{"facility":70,"status":27,"city":71,"state":7,"zip":72,"country":30,"countryCode":31,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"University Hospital of North Norway","Tromsø","9038",{"type":33,"coordinates":74},[75,76],18.95508,69.6489,{"lat":76,"lon":75},[79],{"name":80,"role":18,"phone":81,"phoneExt":7,"email":82},"Hege S. Haugnes, MD, PhD","+47 77 75 43 42","hege.sagstuen.haugnes@unn.no",{"facility":84,"status":56,"city":85,"state":7,"zip":86,"country":87,"countryCode":88,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Sahlgrenska University Hospital","Gothenburg","41345","Sweden","SE",{"type":33,"coordinates":90},[91,92],11.96679,57.70716,{"lat":92,"lon":91},[95],{"name":96,"role":18,"phone":97,"phoneExt":7,"email":98},"Anna G. Bergdahl, MD, PhD","+46 31 342 90 26","anna.grenabo@vg.region.se",{"facility":100,"status":27,"city":101,"state":7,"zip":7,"country":87,"countryCode":88,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Karolinska University Hospital","Stockholm",{"type":33,"coordinates":103},[104,105],18.06871,59.32938,{"lat":105,"lon":104},[108,111],{"name":109,"role":18,"phone":7,"phoneExt":7,"email":110},"Anna Thor, MD","anna.thor@ki.se",{"name":112,"role":18,"phone":113,"phoneExt":7,"email":114},"Anders Kjellman, MD, PhD","+46 073 699 52 58","anders.kjellman@sll.se",{"type":116,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[118,119,120,122,123],{"name":100,"class":6},{"name":84,"class":6},{"name":121,"class":6},"Helse Fonna",{"name":70,"class":6},{"name":55,"class":6},"100432662","microrna-as-markers-in-testicular-cancer-100432662",false,"NCT04914026","MicroRNA as Markers in Testicular Cancer","MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours","Inclusion Criteria:\n\n* Patients with suspected testicular cancer, referred to orchiectomy.\n* Patients diagnosed with testicular germ cell cancer.\n* Age 18-70 years of age.\n* Must be able receive information and to consent.\n\nExclusion Criteria:\n\n* Other prior or concomitant malignancy (other than testicular cancer).\n* Other diseases or conditions that hinder the ability to receive information and to participate in follow-up procedures.","MALE","18 Years","70 Years",{"count":135,"type":136},350,"ESTIMATED","OBSERVATIONAL","The main objective of this study is establish the performance of miR371 in management of testicular cancer",[140,141,142,143,144,145,146,147],"Testicular Germ Cell Cancer","Seminoma","Non-Seminoma Testicular Cancer","Stage I Testicular Cancer","Stage II Testicular Cancer","Stage III Testicular Cancer","Stage IV Testicular Cancer","Relapse Testicular Cancer","2022-08-05",{"date":150,"type":151},"2022-08-08","ACTUAL",{"date":153,"type":151},"2016-12-31",{"date":155,"type":136},"2026-12-31",{"name":5,"class":6},6]